PEMETREXED VERSUS PEMETREXED PLUS CARBOPLATIN IN PRETREATED PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS OF TWO RANDOMIZED TRIALS

被引：0
|
作者：
Tiseo, Marcello [1 ]
Ardizzoni, Andrea [1 ]
Boni, Luca [2 ]
Vincent, A. [3 ]
Buti, S.
Camerini, Andrea
Labianca, R. [4 ]
Genestreti, Giovenzio [5 ]
Zanelli, Francesca [6 ]
Ciuffreda, L. [7 ]
Di Costanzo, F. [8 ]
De Marinis, F. [9 ]
Crino, Lucio [10 ]
Santo, A. [11 ]
Pazzola, A. [12 ]
Barbieri, F. [13 ]
Zilembo, N. [14 ]
Colantonio, I. [15 ]
Tibaldi, C. [16 ]
Smit, Egbert F. [17 ]
机构：
[1] Univ Hosp Parma, Med Oncol Unit, Parma, Italy
[2] Ist Toscano Tumori, Coordinamento Sperimentaz Clin 4Ctr, Genoa, Italy
[3] Natl Canc Inst, Amsterdam, Netherlands
[4] Osped Riuniti Bergamo, Bergamo, Italy
[5] Irst Meldola, Oncol, Melola, Italy
[6] Osped Reggio Emilia, Reggio Emilia, Italy
[7] Osped Molinette, Molinette, Italy
[8] Osped Careggi, Florence, Italy
[9] San Camillo Forlanini, Rome, Italy
[10] Osped Perugia, Perugia, Italy
[11] Osped Verona, Verona, Italy
[12] Osped Sassari, Sassari, Italy
[13] Policlin Modena, Modena, Italy
[14] Ist Nazl Tumori, Naples, Italy
[15] Osped Cuneo, Cuneo, Italy
[16] Osped Livorno, Livorno, Italy
[17] Vrije Univ, Med Ctr, Pulmonol Dept, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; second-line chemotherapy; Pemetrexed; Carboplatin;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S415 / S415
页数：1
相关论文
共 50 条
  • [31] Erlotinib versus Pemetrexed for Pretreated Non-Squamous Non-Small Cell Lung Cancer Patients in Clinical Practice
    Zugazagoitia, J.
    Puente, J.
    Gonzalez-Larriba, J. L.
    Manzano, A.
    Sotelo, M.
    Hernandez, S.
    Sanz, J.
    Perez, P.
    Diaz-Rubio, E.
    ONCOLOGY, 2013, 84 (05) : 255 - 264
  • [32] Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab for Japanese nonsquamous non-small cell lung cancer
    Yokoi, Takashi
    Torii, Yoshitaro
    Katashiba, Yuichi
    Sugimoto, Hiroyuki
    Hayashi, Mina
    Shimizu, Toshiki
    Nomura, Shosaku
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancer
    Karayama, Masato
    Inui, Naoki
    Fujisawa, Tomoyuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Kuroishi, Shigeki
    Yokomura, Koshi
    Koshimizu, Naoki
    Sato, Masaki
    Toyoshima, Mikio
    Shirai, Toshihiro
    Masuda, Masafumi
    Yamada, Takashi
    Imokawa, Shiro
    Suda, Takafumi
    EUROPEAN JOURNAL OF CANCER, 2016, 58 : 30 - 37
  • [34] Pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for advanced non-squamous non-small cell lung cancer (NSCLC)
    Patel, J. D.
    Hensing, T. A.
    Rademaker, F.
    Hart, E.
    Obasaju, C. K.
    Treat, J.
    Milton, D.
    Bonomi, P. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] FINAL ANALYSIS OF DOSE ESCALATION STUDY OF CARBOPLATIN PLUS PEMETREXED FOLLOWED BY MAINTENANCE PEMETREXED FOR ELDERLY PATIENTS (≥75 YEARS OLD) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Tamiya, Motohiro
    Tamiya, Akihiro
    Shiroyama, Takayuki
    Kanazu, Masaki
    Hirooka, Aya
    Tsuji, Taisuke
    Morishita, Naoko
    Asami, Kazuhiro
    Suzuki, Hidekazu
    Okamoto, Norio
    Okishio, Kyoichi
    Kawaguchi, Tomoya
    Hirashima, Tomonori
    Atagi, Shinji
    Kawase, Ichiro
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1162 - S1163
  • [36] Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancer
    Okamoto, Isamu
    Takeda, Koji
    Daga, Haruko
    Miyazaki, Masaki
    Yonesaka, Kimio
    Kiyota, Hidemi
    Tsurutani, Junji
    Ueda, Shinya
    Ichikawa, Yasuko
    Takeda, Masayuki
    Sekiguchi, Risa
    Tominaga, Kiyomi
    Enatsu, Sotaro
    Nambu, Yoshihiro
    Nakagawa, Kazuhiko
    LUNG CANCER, 2010, 70 (02) : 168 - 173
  • [37] PEMETREXED AND CARBOPLATIN VERSUS DOCETAXEL AND CARBOPLATIN AS FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED, NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (NSCLC)
    Ganju, Vinod
    Pereira, Jose
    Kim, Joo-Hang
    Magallanes, Manuel
    Lee, Dae-Ho
    Wang, Jie
    Martinez, Luis
    Barraclough, Helen
    Van Kooten, Maximiliano
    Orlando, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S417 - S418
  • [38] A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer
    Spigel, David R.
    Hainsworth, John D.
    Shipley, Dianna L.
    Ervin, Thomas J.
    Kohler, Peter C.
    Lubiner, Eric T.
    Peyton, James D.
    Waterhouse, David M.
    Burris, Howard A., III
    Greco, F. Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (01) : 196 - 202
  • [39] A phase II study of pemetrexed and carboplatin as a salvage therapy for platinum-pretreated patients with non-small cell lung cancer
    Kim, Hyeong Su
    Lee, Gyeong-Won
    Kim, Jung Han
    Kim, Ho Young
    Kwon, Jung Hye
    Song, Hun Ho
    Kim, Hyo Jung
    Jung, Joo Young
    Jang, Geundoo
    Choi, Dae Ro
    Park, Sang Myeon
    Shin, Tae Rim
    Lee, Hee-sung
    Zang, Dae Young
    LUNG CANCER, 2010, 70 (01) : 71 - 76
  • [40] Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial
    Hanna, Nasser H.
    Kaiser, Rolf
    Sullivan, Richard N.
    Aren, Osvaldo Rudy
    Ahn, Myung-Ju
    Tiangco, Beatrice
    Voccia, Isabelle
    von Pawel, Joachim
    Kovcin, Vladimir
    Agulnik, Jason
    Gaschler-Markefski, Birgit
    Barrueco, Jose
    Sikken, Patricia
    Schloss, Charles
    Kim, Joo-Hang
    LUNG CANCER, 2016, 102 : 65 - 73
12345